FDMT
FDMT
US35104E1001
4D Molecular Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
736.41M EUR
734.35M EUR
486.65M EUR
432.06M EUR
Enterprise Value
379.48M EUR
703.19M EUR
434.7M EUR
393.23M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-3.26x
--
--
--
Price to Sales
8x
7.98x
5.51x
5.07x
Price to Book
1.81x
1.8x
1.08x
0.85x
EV/Revenue
4.12x
7.64x
4.93x
4.62x
EV/EBITDA
-2.01x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-12.33%
-21.24%
-26.58%
-14.17%
ende